1-2 of 2
Yii-Jenq Lan, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study

Ming-Chung Kuo, MD, Tsai-Yun Chen, MD, Ming-Chung Wang, MD, Youngsen Yang, MD, Su-Peng Yeh, MD, Cheng-Shyong Chang, MD, Yii-Jenq Lan, MD, Chih-Cheng Chen, MD, Yu-Chieh Su, MD, Pei-Ching Hsiao, MD, Ching-Yuan Kuo, MD, Li-Yuan Bai, MD, Wen-Li Hwang, MD, Lee-Yung Shih, MD
Journal: Blood
Blood (2014) 124 (21): 4544.
https://doi.org/10.1182/blood.V124.21.4544.4544
Published: 2014
Journal Articles

EEC Growth, JAK2 Mutation, PRV-1 Overexpression and X-Chromosome Inactivation Pattern: Predicting Values on Polycythemia Vera Evolution and Risk of Thrombosis in Idiopathic Thrombocytosis.

Lee-Yung Shih, MD, Ching-Tai Lee, BS, Tung-Liang Lin, MD, Chia-Hui Chang, BS, Chein-Fuang Huang, PhD, Po-Nan Wang, MD, Ming-Chung Kuo, MD, Po Dunn, MD, Jin-Hou Wu, MD, Hung Chang, MD, Yii-Jenq Lan, MD, Tzung-Chih Tang, MD
Journal: Blood
Blood (2006) 108 (11): 2692.
https://doi.org/10.1182/blood.V108.11.2692.2692
Published: 2006